University of California San Francisco
Give to UCSFRegular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UCSF has found.
UCSF's Thea Tlsty is a winner of the “Grand Challenge” competition sponsored by Cancer Research UK. Her international team will receive $26 million to uncover how chronic inflammation causes cancer.
In laboratory experiments, UCSF researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach.
The amount of radiation that patients are exposed to from CT scans varies widely between institutions and countries, and is largely due to differences in the technical settings of the scanning machines.
Cynthia Perlis shares her top learnings from 30 years of listening to cancer patients at UCSF.
Study, led by UCSF, raises intriguing questions about whether the biology of low-risk prostate cancer in black men is distinct from that of other ethnicities.
From sensory processing disorder to how CRISPR is being explored to bring new treatments to patients, these are the stories that most engaged our readers in 2018.
Anxiety and depression may be leading predictors of conditions ranging from heart disease to headaches, having similar effects as long-established risk factors like smoking and obesity.
UCSF scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies.
A UCSF surgeon is among a handful nationwide who are pioneering and studying the outcomes of a new approach to breast reconstruction.
UCSF researchers have devised a CRISPR-based system called SLICE, which will allow scientists to rapidly assess the function of each and every gene in “primary” immune cells.
Using a mouse model, researchers showed that a drug that temporarily suppresses a key component of the brain’s immune system can prevent radiation-associated cognitive decline.
Study found that simple cysts are normal, extremely common and aren’t linked to a higher risk of ovarian cancer. As a result, unless they are symptomatic, simple cysts can be safely ignored.
UCSF demonstrates that cancer is a clever engineer, capable of constructing entirely new disease-promoting networks out of raw materials readily available in the cell.
The Quantitative Biosciences Institute attracts investigators on the basis of the tools and techniques they employ, rather than the diseases they study.
Claims by the tobacco industry that heated tobacco products (HTPs) are safer than conventional cigarettes are not supported by the industry’s own data and are likely to be misunderstood by consumers.
A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even before changes are identified on scans.
Scientists at UCSF and Boston Children’s Hospital have developed a new technique for making mice with brains that combine the genetics of two different mouse strains.